GETINGE AB UNSP ADR EACH REPR 1 (GNGBY) Financials
GNGBY Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 4.9 billion | 2.0 billion |
| 2023-06-30 | 4.8 billion | 2.0 billion |
| 2023-03-31 | 4.9 billion | 1.9 billion |
GNGBY Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | ? | ? |
| 2023-09-30 | 97.8 million | ? |
| 2023-06-30 | 24.8 million | ? |
| 2023-03-31 | -69.3 million | ? |
GNGBY Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 71.3 million |
| 2023-09-30 | 120.4 million |
| 2023-06-30 | 35.3 million |
| 2023-03-31 | 86.9 million |
GNGBY Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | - |
| 2023-09-30 | 488.7 million | - | 127.2 million |
| 2023-06-30 | 408.6 million | - | 131.8 million |
| 2023-03-31 | 446.3 million | - | 134.6 million |
GNGBY Shares Outstanding
GNGBY Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | - | - | - | - |
| 2023-09-30 | 31.4 million | 25.7 million | 96.5 million | 119.0 million |
| 2023-06-30 | 35.0 million | 24.9 million | 98.0 million | 120.4 million |
| 2023-03-31 | 28.1 million | 28.6 million | 95.6 million | 125.5 million |
GNGBY Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | - |
| 2023-09-30 | 696.6 million | 367.8 million |
| 2023-06-30 | 661.2 million | 375.7 million |
| 2023-03-31 | 689.0 million | 349.5 million |
GNGBY
Price: $21.85
Dividend Yield: 0.22%
Forward Dividend Yield: 1.94%
Payout Ratio: 52.71%
Dividend Per Share: 0.42 USD
Earnings Per Share: 0.84 USD
P/E Ratio: 23.99
Exchange: PNK
Sector: Healthcare
Industry: Medical Devices
Volume: 7753
Ebitda: 698.1 millionMarket Capitalization: 5.6 billion
Average Dividend Frequency: 1
Years Paying Dividends: 13
DGR3: 30.00%
DGR5: 30.00%
DGR10: 21.77%